Cutaneous photoprotection and melanoma susceptibility: Reaching beyond melanin content to the frontiers of DNA repair

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2157-2173

  Kadekaro, Ana Luisa ^a   Wakamatsu, Kazumasa ^b   Ito, Shosuke ^b   Abdel Malek, Zalfa A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Cancer; DNA Repair; Melanocyte; Melanoma Risk; Photoprotection; Pigment; Pigmentary Phenotype; Skin

Indexed keywords

EID: 33744826277     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1958     Document Type: Review

References (133)

1. M A Pathak & T B Fitzpatrick. The role of natural photoprotective agents in human skin. In: Sunlight and Man. Eds: Fitzpatrick T B, Pathak M A, Haber L C, Seiji M, Kukita A. University of Tokyo Press, Tokyo. 725-50. (1974)
2. A M Dillman. Photobiology of skin pigmentation. In: Pigmentation and Pigmentary Disorders. Eds: Levine N. CRC Press, Inc., Boca Raton. 61-94. (1993)
3. M A Pathak, K Jimbow & T Fitzpatrick. Phenotypic expression in pigment cells. In: Photobiology of Pigment Cell. Eds: Seiji M. University of Tokyo Press, Tokyo, Japan. 655-70. (1980)
4. Gilchrest B.A, M.S. Eller, A.C. Geller & M. Yaar: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340(17), 1341-1348 (1999)
5. Epstein J.H: Photocarcinogenesis, skin cancer and aging. J Am Acad Dermatol 9, 487-502 (1983)
6. Sober A.J, R.A. Lew, H.K. Koh & R.L. Barnhill: Epidemiology of cutaneous melanoma. An update. Dermatol Clin 9, 617-29 (1991)
7. Kraemer K.H: Nucleotide excision repair genes involved in xeroderma pigmentosum. Jpn J Cancer Res 85, inside front cover (1994)
8. Wei Q, J.E. Lee, J.E. Gershenwald, M.I. Ross, P.F. Mansfield, S.S. Strom, L.E. Wang, Z. Guo, Y. Qiao, C.I. Amos, M.R. Spitz & M. Duvic: Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95(4), 308-15 (2003)
9. Sarkar-Agrawal P., I. Vergilis, N.E. Sharpless, R.A. Depinho & T.M. Runger: Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF. J Natl Cancer Inst 96(23), 1790-3 (2004)
10. Kadekaro A.L, R. Kavanagh, H. Kanto, S. Terzieva, J. Hauser, N. Kobayashi, S. Schwemberger, J. Cornelius, G. Babcock, H.G. Shertzer, G. Scott & Z.A. Abdel-Malek: a-Melanocortin and endothelin-1 activate anti-apoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65(10), 4292-9 (2005)
11. Zhai S, M. Yaar & B.A. Gilchrest: Nerve growth factor rescues pigment cells from ultraviolet induced apoptosis by upregulating BCL-2 levels. Exp Cell Res 224, 335-43 (1996)
12. Yaar M, M.S. Eller, P. Dibenedetto, W.R. Reenstra, S. Zhai, T. Mcquiad, M. Archambault & B.A. Gilchrest: The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 94, 1550-62 (1994)
13. Grichnik J.M, J.A. Burch, J. Burchette & C.R. Shea: The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 111(2), 233-8 (1998)
14. Suzuki I, R. Cone, S. Im, J. Nordlund & Z. Abdel-Malek: Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137, 1627-33 (1996)
15. Scott M.C, K. Wakamatsu, S. Ito, A.L. Kadekaro, N. Kobayashi, J. Groden, R. Kavanagh, T. Takakuwa, V. Virador, V.J. Hearing & Z.A. Abdel-Malek: Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 115, 2349-55 (2002)
16. Valverde P, E. Healy, I. Jackson, J.L. Rees & A.J. Thody: Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11, 328-30 (1995)
17. Box N.F, J.R. Wyeth, L.E. O'gorman, N.G. Martin & R.A. Sturm: Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 6, 1891-7 (1997)
18. Sturm R.A, N.F. Box & M. Ramsay: Human pigmentation genetics: the difference is only skin deep. Bioessays 20, 712-21 (1998)
19. Smith R, E. Healy, S. Siddiqui, N. Flanagan, P.M. Steijlen, I. Rosdahl, J.P. Jacques, S. Rogers, R. Turner, I.J. Jackson, M.A. Birch-Machin & J.L. Rees: Melanocortin 1 receptor variants in Irish population. J Invest Dermatol 111, 119-22 (1998)
20. Rana B.K, D. Hewett-Emmett, L. Jin, B.H.-J. Chang, N. Sambuughin, M. Lin, S. Watkins, M. Bamshad, L.B. Jorde, M. Ramsay, T. Jenkins & W.-H. Li: High polymorphism at the human melanocortin 1 receptor locus. Genetics 151, 1547-57 (1999)
21. Palmer J.S, D.L. Duffy, N.F. Box, J.F. Aitken, L.E. O'gorman, A.C. Green, N.K. Hayward, N.G. Martin & R.A. Sturm: Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am J Hum Genet 66, 176-86 (2000)
22. Valverde P, E. Healy, S. Sikkink, F. Haldane, A.J. Thody, A. Carothers, I.J. Jackson & J.L. Rees: The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 5, 1663-6 (1996)
23. Kennedy C, J. Ter Huurne, M. Berkhout, N. Gruis, M. Bastiaens, W. Bergman, R. Willemze & J.N. Bouwes Bavinck: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117, 294-300 (2001)
24. Van Der Velden P.A, L.A. Sandkuijl, W. Bergman, S. Pavel, L. Van Mourik, R.R. Frants & N.A. Gruis: Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69, 774-9 (2001)
25. Matichard E, P. Verpillat, R. Meziani, B. Gerard, V. Descamps, E. Legroux, M. Burnouf, G. Bertrand, F. Bouscarat, A. Archimbaud, C. Picard, L. Ollivaud, N. Basset-Seguin, D. Kerob, G. Lanternier, C. Lebbe, B. Crickx, B. Grandchamp & N. Soufir: Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41(2), e13 (2004)
26. Landi M.T, P.A. Kanetzky, S. Tsang, B. Gold, D. Munroe, T. Rebbeck, J. Swoyer, M. Ter-Minassian, M. Hedayati, L. Grossman, A.M. Goldstein, D. Calista, & R.M. Pfeiffer: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 97(13), 998-1007 (2005)
27. Ringholm A, J. Klovins, R. Rudzish, S. Phillips, J.L. Rees & H.B. Schioth: Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 123(5), 917-23 (2004)
28. Pathak M.A: Ultraviolet radiation and the development of non-melanoma and melanoma skin cancer: Clinical and experimental evidence. Skin Pharmacol 4 (Suppl 1), 85-94 (1991)
29. Black H.S, F.R. De Gruijl, P.D. Forbes, J.E. Cleaver, H.N. Ananthaswamy, E.C. Defabo, S.E. Ullrich & R.M. Tyrrell: Photocarcinogenesis: an overview. Photochem Photobiol 40, 29-47 (1997)
30. Pathak M.A., Y. Hori, G. Szabo & T.B. Fitzpatrick. The photobiology of melanin pigmentation in human skin. In: Biology of Normal and Abnormal Melanocytes. Eds: T Kawamura, T B Fitzpatrick, M Seiji. University Park Press, Baltimore. 149-69 (1971)
31. Kobayashi N, A. Nakagawa, T. Muramatsu, Y. Yamashina, T. Shirai, M.W. Hashimoto, Y. Ishigaki, T. Ohnishi & T. Mori: Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 110, 806-10 (1998)
32. Kaidbey K.H, P. Poh Agin, R.M. Sayre & A.M. Kligman: Photoprotection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol 1, 249-260 (1979)
33. Tadokoro T, N. Kobayashi, B.Z. Zmudzka, S. Ito, K. Wakamatsu, Y. Yamaguchi, K.S. Korossy, S.A. Miller, J.Z. Beer & V.J. Hearing: UV-induced DNA damage and melanin content in human skin differeing in racial/ethnic origin. FASEB J 17(9), 1177-9 (2003)
34. Felix C.C, J.S. Hyde, T. Sarna & R.C. Sealy: Melanin photoreaction in aerated media: Electron spin resonance evidence of production of superoxide and hydrogen peroxide. Biochem Biophys Res Commun 84, 335-41 (1978)
35. Bustamante J, L. Bredeston, G. Malanga & J. Mordoh: Role of melanin as a scavenger of active oxygen species. Pigment Cell Res 6, 348-53 (1993)
36. Kricker A, B.K. Armstrong & D.R. English: Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 5, 367-92 (1994)
37. T B Fitzpatrick, A Z Eisen, K Wolff, I M Freedburg & K F Austen. Dermatology in General Medicine, 3rd ed. McGraw Hill, Inc., New York (1987)
38. Halder R.M. & S. Bridgeman-Shah: Skin cancer in African Americans. Cancer 75, 667-73 (1995)
39. Maclennan R, A.C. Green, G.R.C. Mcleod & N.G. Martin: Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84, 1427-32 (1992)
40. Rees J.L: Genetics of hair and skin color. Annu Rev Genet 37, 67-90 (2003)
41. Eller M.S, K. Ostrom & B.A. Gilchrest: DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A 93, 1087-92 (1996)
42. Sheehan J.M, N. Cragg, C.A. Chadwick, C.S. Potten & A.R. Young: Repeated ultraviolet exposure affords the same protection against DNA photodamage and erythema in human skin types II and IV but is associated with faster DNA repair in skin type IV. J Invest Dermatol 118, 825-29 (2002)
43. Thody A.J, E.H. Higgins, K. Wakamatzu, S.A. Burchill & J.M. Marks: Pheomelanin as well as eumelanin is present in human epidermis. J Invest Dermatol 97, 340-4 (1991)
44. Hunt G, S. Kyne, S. Ito, K. Wakamatsu, C. Todd & A.J. Thody: Eumelanin and pheomelanin contents of human epidermis and cultured melanocytes. Pigment Cell Res 8, 202-8 (1995)
45. Menon IA, S. Persad, N.S. Ranadive, H.F. Haberman: Photobiological effects of eumelanin and pheomelanin. In: Biological, Molecular and Clinical Aspects of Pigmentation. Eds: J.T. Bagnara, S.N. Klaus, E. Paul, M. Schartl. University of Tokyo Press, Tokyo. 77-86 (1985)
46. Alaluf S, D. Atkins, K. Barret, M. Blount, N. Carter & A. Heath: The impact of epidermal melanin on objective measurements of human skin colour. Pigment Cell Res 15(2), 119-26 (2002)
47. Kadekaro A.L, R.J. Kavanagh, K. Wakamatsu, S. Ito, M.A. Pipitone & Z.A. Abdel-Malek: Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round? Pigment Cell Res 16(5), 434-47 (2003)
48. Iwata M, T. Corn, S. Iwata, M.A. Everett & B.B. Fuller: The relationship between tyrosinase activity and skin color in human foreskins. J Invest Dermatol 95, 9-15 (1990)
49. Abdel-Malek Z, V. Swope, C. Collins, R. Boissy, H. Zhao & J. Nordlund: Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J Cell Sci 106, 1323-31 (1993)
50. Abdel-Malek Z.A, V.B. Swope, J.J. Nordlund & E.E. Medrano: Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site. Pigment Cell Res 7, 116-22 (1994)
51. Fuller B.B, D.T. Spaulding & D.R. Smith: Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. Exp Cell Res 262(2), 197-208 (2001)
52. Smith D.R, D.T. Spaulding, H.M. Glenn & B.B. Fuller: The relationship between Na(+)/H(+) exchanger expression and tyrosinase activity in human melanocytes. Exp Cell Res 298(2), 521-34 (2004)
53. Tamate H.B. & T. Takeuchi: Action of the e locus of mice in the response of phaeomelanic hair follicles to a-melanocyte-stimulating hormone in vitro. Science 224, 1241-2 (1984)
54. 7 a-melanocyte-stimulating hormone increases the eumelanin:phaeomelanin ratio in cultured human melanocytes. J Invest Dermatol 104, 83-5 (1995)
55. Krude H, H. Biebermann, W. Luck, R. Horn, G. Brabant & A. Gruters: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19, 155-7 (1998)
56. Mountjoy K.G, L.S. Robbins, M.T. Mortrud & R.D. Cone: The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-51 (1992)
57. Smith A.I. & J.E. Funder: Proopiomelanocortin processing in the pituitary, central nervous system and peripheral tissues. Endocr Rev 9, 159-79 (1988)
58. Wilson B.D, M.M. Ollmann, L. Kang, M. Stoffel, G.I. Bell & G.S. Barsh: Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 4, 223-30 (1995)
59. Suzuki I, A. Tada, M.M. Ollmann, G.S. Barsh, S. Im, M.L. Lamoreux, V.J. Hearing, J. Nordlund & Z.A. Abdel-Malek: Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to a-melanotropin. J Invest Dermatol 108, 838-42 (1997)
60. Abdel-Malek Z, V.B. Swope, I. Suzuki, C. Akcali, M.D. Harriger, S.T. Boyce, K. Urabe & V.J. Hearing: Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci U S A 92, 1789-93 (1995)
61. Sakai C, M. Ollmann, T. Kobayashi, Z. Abdel-Malek, J. Muller, W.D. Vieira, G. Imokawa, G.S. Barsh & V.J. Hearing: Modulation of murine melanocyte function {Iin vitro} by agouti signal protein. EMBO J 16, 3544-52 (1997)
62. Abdel-Malek Z.A, M.C. Scott, M. Furumura, M.L. Lamoreux, M. Ollmann, G.S. Barsh & V.J. Hearing: The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J Cell Sci 114, 1019-24 (2001)
63. Harding R.M, E. Healy, A.J. Ray, N.S. Ellis, N. Flanagan, C. Todd, C. Dixon, A. Sajantila, I.J. Jackson, M.A. Birch-Machin & J.L. Rees: Evidence for variable selective pressures at MC1R. Am J Hum Genet 66, 1351-61 (2000)
64. Flanagan N, E. Healy, A. Ray, S. Philips, C. Todd, I.J. Jackson, M.A. Birch-Machin & J.L. Rees: Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 9, 2531-7 (2000)
65. Healy E, N. Flannagan, A. Ray, C. Todd, I.J. Jackson, J.N. Matthews, M.A. Birch-Machin & J.L. Rees: Melanocortin-1 receptor gene and sun sensitivity in individuals without red hair. Lancet 355, 1072-3 (2000)
66. Brash D.E, J.A. Rudolph, J.A. Simon, A. Lin, G.J. Mckenna, H.P. Baden, A.J. Halperin & P.N. J.: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 88, 10124-8 (1991)
67. Ziegler A, D.J. Leffell, S. Kunala, H.W. Sharma, M. Gailani, J.A. Simon, A.J. Halperin, H.P. Baden, P.E. Shapiro & A.E. Bale: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 90, 4216-20 (1993)
68. Pfeifer G.P, Y.-H. You & A. Besaratinia: Mutations induced by ultraviolet light. Mutat Res 571, 19-31 (2005)
69. Lubbe J, M. Reichel, G. Burg & P. Kleihues: Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 102, 819-21 (1994)
70. Setlow R.B, E. Grist, K. Thompson & A.D. Woodhead: Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 90, 6666-70 (1993)
71. Drobetsky E.A, J. Turcotte & A. Chateauneuf: A role for ultraviolet A in solar mutagenesis. Proc Natl Acad Sci U S A 92, 2350-4 (1995)
72. De Fabo E.C, F.P. Noonam, T. Fears & G. Merlino: Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 64(18), 6372-6 (2004)
73. Cadet J, E. Sage & T. Douki: Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 571, 3-17 (2005)
74. Pollock P.M, F. Yu, L. Qiu, P.G. Parsons & N.K. Hayward: Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene 11, 663-8 (1995)
75. Flores J.F, G.J. Walker, J.M. Glendening, F.G. Haluska, J.S. Castresana, M.P. Rubio, G.C. Pastorfide, L.A. Boyer, W.H. Kao, M.L. Bulyk, R.L. Barnhill, N.K. Hayward, D.E. Housman & J.W. Fountain: Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res 56(21), 5023-32 (1996)
76. Barker D, K. Dixon, E.E. Medrano, D. Smalara, S. Im, D. Mitchell, G. Babcock & Z.A. Abdel-Malek: Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res 55:4041-6 (1995)
77. Smit N.P.M, A.A. Vink, R.M. Kolb, M.-J.S.T. Steenwinkel, P.T.M. Van Den Berg, F. Van Nieuwpoort, L. Roza & S. Pavel: Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol 74, 424-30 (2001)
78. Hauser J.E, A.L. Kadekaro, S. Terzieva, R.J. Kavanagh, G. Lemasters & Z.A. Abdel-Malek: Assesssment of UV-Induced DNA Photoproducts and Their Repair in Cultured Normal Human Melanocytes: Role of Constitutive Melanin Content and MC1R Status. 12th Annual Meeting for the PanAmerican Society for Pigment Cell Research, Newport Beach,CA (2004)
79. Rosette C. & M. Karin: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274, 1194-7 (1996)
80. Ono K. & J. Han: The p38 signal transduction pathway. Activation and function. Cell Signal 12, 1-13 (2000)
81. Waf-1/SDI/Cip-1 protein. Cancer Res 55, 4047-52 (1995)
82. Tada A, E. Pereira, D. Beitner Johnson, R. Kavanagh & Z.A. Abdel-Malek: Mitogen and ultraviolet-B-induced signaling pathways in normal human melanocytes. J Invest Dermatol 118, 316-322 (2002)
83. Levine A.J: p53, the cellular gatekeeper for growth and division. Cell 88, 323-31 (1997)
84. Veis D.J, C.M. Sorenson, J.R. Shutter & S.J. Korsmeyer: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75(2), 229-40 (1993)
85. Im S, O. Moro, F. Peng, E.E. Medrano, J. Cornelius, G. Babcock, J. Nordlund & Z. Abdel-Malek: Activation of the cyclic AMP pathway by a-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res 58, 47-54 (1998)
86. Tada A, I. Suzuki, S. Im, M.B. Davis, J. Cornelius, G. Babcock, J.J. Nordlund & Z.A. Abdel-Malek: Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 9, 575-84 (1998)
87. Chakraborty A.K, Y. Funasaka, A. Slominski, G. Ermak, J. Hwang, J.M. Pawelek & M. Ichihashi: Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1313, 130-8 (1996)
88. Imokawa G, Y. Yada & M. Miyagishi: Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 267, 24675-80 (1992)
89. Abdel-Malek Z, M.C. Scott, I. Suzuki, A. Tada, S. Im, L. Lamoreux, S. Ito, G. Barsh & V. Hearing: The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 13(8), 156-62 (2000)
90. FAK phosphorylation. Exp Cell Res 237, 19-28 (1997)
91. Swope V.B, E.E. Medrano, D. Smalara & Z. Abdel-Malek: Long-term proliferation of human melanocytes is supported by the physiologic mitogens a-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp Cell Res 217, 453-9 (1995)
92. Scott M.C, I. Suzuki & Z.A. Abdel-Malek: Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors, and by UV radiation. Pigment Cell Res 15, 433-9 (2002)
93. Marrot L, J.P. Belaidi, C. Jones, P. Perez & J.R. Meunier: Molecular responses to stress induced in normal human caucasian melanocytes in culture by exposure to simulated solar UV. Photochem Photobiol 81(2), 367-75 (2005)
94. Abdel-Malek Z.A, A.L. Kadekaro, J. Hauser, S. Terzieva, R. Kavanagh & S. Leachman: Loss of Function Alleles of The Melanocortin-1 Receptor Gene Increase the Risk for melanoma by Increasing UV-Induced Oxidative Stress and Reducing the Repair of DNA Photoproducts. 66th Annual Meeting of the Society for Investigative Dermatology. Eds., Saint Louis, MO. (2005)
95. Plettenberg A, C. Ballaun, J. Pammer, M. Mildner, D. Strunk, W. Weninger & E. Tschachler: Human melanocytes and melanoma cells constitutively express the bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 146, 651-9 (1995)
96. Fuchs E: Epidermal differentiation: The bare essentials. J Cell Biol 111, 2807-14 (1990)
97. Zhai S, M. Yaar, W.R. Reenstra & B.A. Gilchrest: Nerve growth factor (NGF) enhances survival of human melanocytes. J Invest Dermatol 101, 434 (1993)
98. Fleischman R.A, D.L. Saltman, V. Stastny & S. Zneimer: Deletion of the c-kit proto-oncogene in the human developmental defect piebald trait. Proc Natl Acad Sci U S A 88, 10885-9 (1991)
99. Hachiya A, A. Kobayashi, A. Ohuchi, Y. Takema & G. Imokawa: The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation. J Invest Dermatol 116, 578-86 (2001)
100. Datta S.R, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh & M.E. Greenberg: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-41 (1997)
101. Price E.R, M.A. Horstmann, A.G. Wells, K.N. Weilbaecher, C.M. Takemoto, M.W. Landis & D.E. Fisher: a-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem 273, 33042-7 (1998)
102. Pugazhenthi S, A. Nesterova, C. Sable, K.A. Heidenreich, L.M. Boxer, L.E. Heasley & J.E.-B. Reusch: Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275, 10761-6 (2000)
103. Hirobe T, Y. Kawa, M. Mizoguchi, S. Ito, K. Wakamatsu: Effects of genic substitution at the pink-eyed dilution locus on the proliferation and differentiation of mouse epidermal melanocytes in vivo and in vitro. J Exp Zool 292(4), 351-66 (2002)
104. Orlow S.J. & M.H. Brilliant: The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanossomal proteins in the eye. Exp Eye Res 68(2), 147-54 (1999)
105. Staleva L, P. Manga & S.J. Orlow: Pink-eyed dilution protien modulates arsenic sensitivity and intracellular glutathione metabolism. Mol Biol Cell 13, 4206-20 (2002)
106. Duffy D.L, N.F. Box, W. Chen, J.S. Palmer, G.W. Montgomery, M.R. James, N.K. Hayward, N.G. Martin & R.A. Sturm: Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13(4), 447-61 (2004)
107. Jannot A.S, R. Meziani, G. Bertrand, B. Gerard, V. Descamps, A. Archibaud, C. Picard, L. Ollivaud, N. Basset-Seguin, D. Kerob, G. Lanternier, C. Lebbe, P. Saiag, B. Crickx, F. Clerget-Darpoux, B. Grandchamp, N. Soufir & Melan-Cohort: Allele variations in the OCA2 gene (pink-eyed dilution locus) are associated with genetic susceptibility to melanoma. Eur J Hum Genet Epub ahead of print (2005)
108. Kamb A, N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day, 3rd, B.E. Johnson & M.H. Skolnick: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264(5157), 436-40 (1994)
109. Kamb A: Role of a cell cycle regulator in hereditary and sporadic cancer. Cold Spring Harb Symp Quant Biol 59, 39-47 (1994)
110. Stone S, P. Jiang, P. Dayananth, S.V. Tavtigian, H. Katcher, D. Parry, G. Peters & A. Kamb: Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 55(14), 2988-94 (1995)
111. Hussussian C.J, J.P. Struewing, A.M. Goldstein, P.A. Higgins, D.S. Ally, M.D. Sheahan, W.H. Clark, Jr, M.A. Tucker & N.C. Dracopoli: Germline p16 mutations in familial melanoma. Nat Genet 8, 15-21 (1994)
112. Zuo L, J. Weger, Q. Yang, A.M. Goldstein, M.A. Tucker, G.J. Walker, N. Hayward & N.C. Dracopoli: Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12, 97-9 (1996)
113. Mackie R.M, T. Freudenberger & T.C. Aitchison: Personal risk-factor chart for cutaneous melanoma. Lancet 2, 487-90 (1989)
114. Serrano M, G.J. Hannon & D. Beach: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366(6456), 704-7 (1993)
115. Hollingsworth R.E, Jr, C.E. Hensey & W.H. Lee: Retinoblastoma protein and the cell cycle. Curr Opin Genet Dev 3(1), 55-62 (1993)
116. Kastan M.B, O. Onyekwere, D. Sidransky, B. Vogelstein & R.W. Craig: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51, 6304-11 (1991)
117. Wolfel T, M. Hauer, J. Schneider, M. Serrano, C. Wolfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K.H. Meyer Zum Buschenfelde & D. Beach: A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269(5228), 1281-4 (1995)
118. Dracopoli N.C. & J.W. Fountain: CDKN2 mutations in melanoma. Cancer Surv 26, 115-32 (1996)
119. Pomerantz J, N. Schreiber-Agus, N.J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Poles, K. Chen, I. Orlow, H.W. Lee, C. Cordon-Cardo & R.A. Depinho: The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92(6), 713-23 (1998)
120. De Stanchina E, M.E. Mccurrach, F. Zindy, S.Y. Shieh, G. Ferbeyre, A.V. Samuelson, C. Prives, M.F. Roussel, C.J. Sherr & S.W. Lowe: E1A signaling to p53 involves the p 19(ARF) tumor suppressor. Genes Dev 12(15), 2434-42 (1998)
121. Smith M.L, I.-T. Chen, Q. Zhan, P.M. O'connor & A.J. Fornace Jr: Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10, 1053-9 (1995)
122. Bates S. & K.H. Vousden: p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6:12-19 (1996)
123. Sharpless N.E. & L. Chin: The INK4a/ARF locus and melanoma. Oncogene 22, 3092-8 (2003)
124. Box N.F, D.L. Duffy, W. Chen, M. Stark, N.G. Martin, R.A. Sturm & N.K. Hayward: MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 69, 765-73 (2001)
125. Davies H, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M.J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Ewing, Y. Floyd, K. Gray, S. Hall, R. Hawes, J. Hughes, V. Kosmidou, A. Menzles, C. Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, R. Wilson, H. Jayatilake, B.A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G.J. Riggins, D.D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, J.W.C. Ho, S.Y. Leung, S.T. Yuen, B.L. Weber, H.F. Seigler, T.L. Darrow, H. Paterson, R. Marais, C.J. Marshall, R. Wooster, M.R. Stratton & P.A. Futreal: Mutations of the BRAF gene in human cancer. Nature 417, 949-54 (2002)
126. Funasaka Y, T. Boulton, M. Cobb, Y. Yarden, B. Fan, S.D. Lyman, D.E. Williams, D.M. Anderson, R. Zakut, Y. Mishima & R. Halaban: c-Kit-Kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3, 197-209 (1992)
127. Hingorani S.R, M.A. Jacobetz, G.P. Robertson, M. Herlyn, D.A. Tuveson: Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res 63(17), 5198-202 (2003)
128. Tucker M.A. & A.M. Goldstein: Melanoma etiology: where are we? Oncogene 22, 3042-52 (2003)
129. 2]. An additional binding site within the human melanocortin receptor 1? Bioorgan Med Chem Lett 14(19), 4839-42 (2004)
130. 2 tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes. J Med Chem 48(9), 3328-36 (2005)
131. Hruby V.J, B.C. Wilkes, M.D. Hadley, F. Al-Obeidi, T.K. Sawyer, D.J. Staples, A.E. Vaux, O. Dym, A.M.L. Castrucci, M.F. Hintz, J.P. Priehm & K.M. Rao: a-Melanotropin: The minimal active sequence in the frog skin bioassay. J Med Chem 30, 2126-30 (1987)
132. Castrucci A.M.L, M.E. Hadley, T.K. Sawyer, B.C. Wilkes, F. Al-Obeidi, D.J. Staples, A.E. De Vaux, O. Dym, M.F. Hintz, J.P. Riehm, K.R. Rao & V.J. Hruby: a-Melanotropin: The minimal active sequence in the lizard skin bioassay. Gen Comp Endocrinol 73, 157-63 (1989)
133. Tadokoro T, Y. Yamaguchi, J. Batzer, S.G. Coelho, B.Z. Zmudzka, S.A. Miller, R. Wolber, J.Z. Beer & V.J. Hearing: Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J Invest Dermatol 124, 1326-32 (2005)